El Sebae, GK, et al. Single-cell murine genetic fate mapping reveals bipotential hepatoblasts and novel multi-organ endoderm progenitors. Development 2018; 145(19). Published online October 11, 2018. doi:10.1242/dev.168658Google Scholar

Tremblay, KD, Zaret, KS. Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Dev Biol 2005;280(1):87–99.CrossRefGoogle ScholarPubMed

Angelo, JR, Tremblay, KD. Laser-mediated cell ablation during post-implantation mouse development. Dev Dyn 2013;242(10):1202–9.Google Scholar

Huppert, SS, Iwafuchi-Doi, M. Molecular regulation of mammalian hepatic architecture. Curr Top Dev Biol 2019;132:91–136.CrossRefGoogle ScholarPubMed

Lemaigre, FP. Development of the intrahepatic and extrahepatic biliary tract: a framework for understanding congenital diseases. Annu Rev Pathol 2019;15:1–22.CrossRefGoogle Scholar

Schaub, JR, et al. De novo formation of the biliary system by TGF beta-mediated hepatocyte transdifferentiation. Nature 2018;557(7704):247–51.Google Scholar

Vestentoft, PS, et al. Three-dimensional reconstructions of intrahepatic bile duct tubulogenesis in human liver. BMC Dev Biol 2011;11:56.Google Scholar

Tanimizu, N, Miyajima, A. Molecular mechanism of liver development and regeneration. Int Rev Cytol 2007;259:1–48.Google Scholar

Deutsch, G, et al. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001;128(6):871–81.Google Scholar

Costa, RH, et al. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003;38(6):1331–47.Google Scholar

Bort, R, et al. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol 2006;290(1):44–56.Google Scholar

Sosa-Pineda, B, Wigle, JT, Oliver, G. Hepatocyte migration during liver development requires Prox1. Nat Genet 2000;25(3):254–5.Google Scholar

Gerard, C, Tys, J, Lemaigre, FP. Gene regulatory networks in differentiation and direct reprogramming of hepatic cells. Semin Cell Dev Biol 2017;66:43–50.CrossRefGoogle ScholarPubMed

Wang, J, et al. FGF signaling is required for anterior but not posterior specification of the murine liver bud. Dev Dyn 2015;244(3):431–43.CrossRefGoogle Scholar

Parviz, F, et al. Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003;34(3):292–6.Google Scholar

Wandzioch, E, Zaret, KS. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 2009;324(5935):1707–10.CrossRefGoogle Scholar

Rossi, JM, et al. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001;15(15):1998–2009.Google Scholar

Palaria, A, et al. Patterning of the hepato-pancreatobiliary boundary by BMP reveals heterogeneity within the murine liver bud. Hepatology 2018;68(1):274–88.Google Scholar

Shih, HP, et al. A gene regulatory network cooperatively controlled by Pdx1 and Sox9 governs lineage allocation of foregut progenitor cells. Cell Rep 2015;13(2):326–36.Google Scholar

Matsumoto, K, et al. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001;294(5542):559–63.Google Scholar

Camp, JG, et al. Multilineage communication regulates human liver bud development from pluripotency. Nature 2017;546(7659):533–8.Google Scholar

Han, S, et al. Endothelial cells instruct liver specification of embryonic stem cell-derived endoderm through endothelial VEGFR2 signaling and endoderm epigenetic modifications. Stem Cell Res 2018;30:163–70.Google Scholar

Planas-Paz, L, et al. The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol 2016;18(5):467–79.Google Scholar

Huch, M, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013;494(7436):247–50.Google Scholar

Prior, N, et al. Lgr5(+) stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool. Development 2019;146(12). Published online June 12, 2019. doi:10.1242/dev.174557Google Scholar

Su, X, et al. Single-cell RNA-Seq analysis reveals dynamic trajectories during mouse liver development. BMC Genomics 2017;18(1):946.Google Scholar

Tanimizu, N, et al. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 2003;116(Pt 9):1775–86.Google Scholar

Yang, L, et al. A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation. Hepatology 2017;66(5):1387–1401.Google Scholar

Ludtke, TH, et al. Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology 2009;49(3):969–78.Google Scholar

Schmelzer, E, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204(8):1973–87.Google Scholar

Segal, JM, et al. Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors. Nat Commun 2019;10(1):3350.Google Scholar

Aizarani, N, et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 2019;572(7768):199–204.CrossRefGoogle ScholarPubMed

MacParland, SA, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun 2018;9(1):4383.Google Scholar

Tarlow, BD, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 2014;15(5):605–18.Google Scholar

Antoniou, A, et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009;136(7):2325–33.Google Scholar

Raynaud, P, et al. A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology 2011;53(6):1959–66.Google Scholar

Benhamouche-Trouillet, S, et al. Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis. Development 2018;145(9). Published online April 30, 2018. doi:10.1242/dev.162123Google Scholar

Takashima, Y, et al. Dynamic three-dimensional morphogenesis of intrahepatic bile ducts in mouse liver development. Hepatology 2015;61(3):1003–11.Google Scholar

Tanimizu, N, et al. Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement in mice. Hepatology 2016;64(1):175–88.Google Scholar

Van Eyken, P, et al. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 1988;8(6):1586–95.Google Scholar

Clotman, F, et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 2005;19(16):1849–54.Google Scholar

Takayama, K, et al. CCAAT/enhancer binding protein-mediated regulation of TGFbeta receptor 2 expression determines the hepatoblast fate decision. Development 2014;141(1):91–100.Google Scholar

McDaniell, R, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006;79(1):169–73.CrossRefGoogle ScholarPubMed

Warthen, DM, et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat 2006;27(5):436–43.Google Scholar

Jeliazkova, P, et al. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 2013;57(6):2469–79.Google Scholar

Sparks, EE, et al. Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice. Hepatology 2010;51(4):1391–400.Google Scholar

Thakurdas, SM, et al. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi). Hepatology 2016;63(2):550–65.CrossRefGoogle Scholar

Zong, Y, et al. Notch signaling controls liver development by regulating biliary differentiation. Development 2009;136(10):1727–39.Google Scholar

Yimlamai, D, et al. Hippo pathway activity influences liver cell fate. Cell 2014;157(6):1324–38.Google Scholar

Zhang, N, et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010;19(1):27–38.CrossRefGoogle ScholarPubMed

Tchorz, JS, et al. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice. Hepatology 2009;50(3):871–9.Google Scholar

Wu, N, et al. The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals. Lab Invest 2017;97(7):843–53.Google Scholar

Desmet, VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation.” Hepatology 1992;16(4):1069–83.Google Scholar

Huppert, SS. A new set of classifications for ductal plate malformations. Hepatology 2011;53(6):1795–7.Google Scholar

Carpentier, R, et al. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology 2011;141(4):1432–8, 1438 e1–4.Google Scholar

Greengard, O. Effects of hormones on development of fetal enzymes. Clin Pharmacol Ther 1973;14:721–6.Google Scholar

Hashimoto, K, Ogara, Y. Epigenetic switching and neonatal nutritional environment. Adv Exp Med Biol 2018;1012:19–25.Google Scholar

Hay, WW Jr. Placental-fetal glucose exchange and fetal glucose metabolism. Trans Am Clin Climatol Assoc 2006;117:321–39; discussion 39–40.Google Scholar

Duval, F, Dos Santos, E, Maury, B, et al. Adiponectin regulates glycogen metabolism at the human fetal-maternal interface. J Mol Endocrinol 2018;61:139–52.Google Scholar

James-Allan, LB, Arbet, J, Teal, SB, et al. Insulin stimulates GLUT4 trafficking to the syncytiotrophoblast basal plasma membrane in the human placenta. J Clin Endocrinol Metab 2019. pii: jc.2018–02778. doi: 10.1210/jc.2018-02778 [Epub ahead of print].Google Scholar

Yubero, P, Hondares, E, Carmona, MC, et al. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism. Endocrinology 2004;145:4268–77.Google Scholar

Vaughan, OR, Rosano, FJ, Powell, T, et al. Regulation of placental amino acid transport and fetal growth. Prog Mol Biol Transl Sci 2017;145:217–51.Google Scholar

Van den Akker, CH, van Goudoever, JB. Recent advances in our understanding of protein and amino acid metabolism in the human fetus. Curr Opin Clin Nutr 2010;13:75–80.Google Scholar

van den Acer, CH, Schierbeek, H, Minderman, G, et al. Amino acid metabolism in the human fetus at term: leucine, valine, and methionine kinetics. Pediatr Res 2011;70:566–71.Google Scholar

Battaglia, FC. Glutamine and glutamate exchange between the fetal liver and the placenta. J Nutr 2000;130(4S Suppl):974S–977S.Google Scholar

Shiojiri, N, Wada, JI, Tanaka, T, et al. Heterogeneous hepatocellular expression of glutamine synthetase in developing mouse liver and in testicular transplants of fetal liver. Lab Invest 1995;72:740–7.Google Scholar

Thomas, B, Gruca, LL, Bennett, C, et al. Metabolism of methionine in the newborn infant: response to the parenteral and enteral administration of nutrients. Pediatr Res 2008;64:381–6.Google Scholar

Bouckenooghe, T, Remacle, C, Reusens, B. Is taurine a functional nutrient? Curr Opin Clin Nutr 2006;9:728–33.Google Scholar

Ghio, A, Bertolotto, A, Resi, V, et al. Triglyceride metabolism in pregnancy. Adv Clin Chem 2011;55:133–53.Google Scholar

Herrera, E, Amusquivar, E, Lopez- Soldado, I, et al. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006;65(Suppl 3):59–64.Google Scholar

Lewis, RM, Wadsack, C, Desoye, G. Placental fatty acid transfer. Curr Opin Clin Nutr Metab Care 2018;21(2):78–82. doi: 10.1097/MCO.0000000000000443.Google Scholar

Herrera, E, Lopez-Soldado, I, Limones, M, et al. Lipid metabolism during the perinatal phase, and its implications on postnatal development. Int J Vitam Nutr Res 2006;76:216–24.Google Scholar

Ehara, E, Kamei, Y, Yuan, X, et al. Ligand-activated PPARα-dependent DNA demethylation regulates the fatty acid β-oxidation genes in the postnatal genes in the postnatal liver. Diabetes 2015;64:775–84.Google Scholar

Pegorier, JP, Prip-Buus, C, Duee, PH, et al. Hormonal control of fatty acid oxidation during the neonatal period. Diabetes Metab 1992;18:156–60.Google Scholar

Haggarty, P. Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr 2004;58:1559–70.Google Scholar

Hong, L, Rosenbaum, S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther 2014;19(4):262–76.Google Scholar

Leeder, JS, Kearns, GL, Spielberg, SP, et al. Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. J Clin Pharmacol 2010;50:1377–87.Google Scholar

Vyhlidal, CA, Gaedigk, R, Leeder, JS. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression. Drug Metab Dispos 2006;34:131–7.Google Scholar

Blake, MJ, Castro, L, Leeder, JS, et al. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonat Metab 2005;10:123–38.Google ScholarPubMed

Matalová, P, Urbánek, K, Anzenbacher, P. Specific features of pharmacokinetics in children. Drug Metab Rev 2016;48(1):70–9.Google Scholar

Zhang, J, Cashman, JR. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos 2006;34:19–26.Google Scholar

Josephy, PD. Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics 2010;2010:876–940. Published June 13, 2010. doi: 10.4061/2010/876940Google Scholar

Hein, DW, Doll, MA, Fretland, AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29–42.Google Scholar

Myllynen, P, Immonen, E, Kummu, M, Vahakangas, K. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 2009;5:1483–99.Google Scholar

Han, LW, Gao, G, Mao, Q. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Expert Opin Drug Metab Toxicol 2018;14:817–29.Google Scholar

Chen, HL, Liu, YJ, Feng, CH, et al. Developmental expression of canalicular transporter genes in human liver. J Hepatol 2005;43:472–7.Google Scholar

Arrese, M, Ananthananarayanan, M, Suchy, FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998;44:141–7.Google Scholar

Colombo, C, Zuliani, G, Ronchi, M, et al. Biliary bile acid composition of the human fetus in early gestation. Pediatr Res 1987;21:197–200.Google Scholar

Balistreri, WF, Heubi, JE, Suchy, FJ. Immaturity of the enterohepatic circulation in early life: factors predisposing to “physiologic” maldigestion and cholestasis. J Pediatr Gastroenterol Nutr 1983;2:346–54.Google Scholar

Watkins, JB, Ingall, D, Szczepanik, P, et al. Bile-salt metabolism in the newborn. Measurement of pool size and synthesis by stable isotope technique. N Engl J Med 1973;288:431–4.Google Scholar

Watkins, JB, Szczepanik, P, Gould, JB, et al. Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology 1975;69:706–13.Google ScholarPubMed

Setchell, KD, Dumaswala, R, Colombo, C, et al. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem 1988;263:16637–44.Google Scholar

Suchy, FJ, Balistreri, WF, Heubi, JE, et al. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80:1037–41.Google Scholar

Itoh, S, Onishi, S, Isobe, K, et al. Foetomaternal relationships of serum bile acid pattern estimated by high-pressure liquid chromatography. Biochem J 1982;204:141–5.Google Scholar

Balistreri, WF. Immaturity of hepatic excretory function and the ontogeny of bile acid metabolism. J Pediatr Gastr Nutr 1983;2(Suppl 1):S207–S214.Google Scholar

Klinger, W. Biotransformation of drugs and other xenobiotics during postnatal development. Pharmacol Ther 1982;16:377–429.Google Scholar

Little, JM, Smallwood, RA, Lester, R, et al. Bile-salt metabolism in the primate fetus. Gastroenterology 1975;69:1315–20.Google Scholar

Bernstein, RB, Novy, MJ, Piasecki, GJ, et al. Bilirubin metabolism in the fetus. J Clin Invest 1969;48:1678–88.Google Scholar

Smallwood, RA, Lester, R, Plasecki, GJ, et al. Fetal bile salt metabolism. II. Hepatic excretion of endogenous bile salt and of a taurocholate load.J Clin Invest 1972;51:1388–97.Google ScholarPubMed

Tavoloni, N, Jones, MJ, Berk, PD. Postnatal development of bile secretory physiology in the dog. J Pediatr Gastroenterol Nutr 1985;4:256–67.Google Scholar

Mohan, P, Ling, SC, Watkins, JB. Ontogeny of hepatobiliary secretion: role of glutathione. Hepatology 1994;19:1504–12.CrossRefGoogle ScholarPubMed

Ho, ML, Chen, JY, Ling, UP, et al. Gallbladder volume and contractility in term and preterm neonates: normal values and clinical applications in ultrasonography. Acta Paediatr 1998;87:799–804.Google Scholar

Jawaheer, G, Pierro, A, Lloyd, DA, et al. Gallbladder contractility in neonates: effects of parenteral and enteral feeding. Arch Dis Child Fetal 1995;72:F200–F202.Google Scholar

Kaplan, GS, Bhutani, VK, Shaffer, TH, et al. Gallbladder mechanics in newborn piglets. Pediatr Res 1984;18:1181–4.Google Scholar

Suchy, FJ, Bucuvalas, JC, Goodrich, AL, et al. Taurocholate transport and Na⁺-K⁺-ATPase activity in fetal and neonatal rat liver plasma membrane vesicles. Am J Physiol 1986;251(5 Pt 1):G665–C673.Google Scholar

Bellemann, P. Amino acid transport and rubidium-ion uptake in monolayer cultures of hepatocytes from neonatal rats. Biochem J 1981;198:475–83.Google Scholar

Belknap, WM, Zimmer-Nechemias, L, Suchy, FJ, Balistreri, WF. Bile acid efflux from suckling rat hepatocytes. Pediatr Res 1988;23:364–7.Google Scholar

Stolz, A, Sugiyama, Y, Kuhlenkamp, J, et al. Cytosolic bile acid binding protein in rat liver: radioimmunoassay, molecular forms, developmental characteristics and organ distribution. Hepatology 1986;6:433–9.Google Scholar

Hardikar, W, Ananthanarayanan, M, Suchy, FJ. Differential ontogenic regulation of basolateral and canalicular bile acid transport proteins in rat liver. J Biol Chem 1995;270:20841–6.Google Scholar

Balasubramaniyan, N, Shahid, M, Suchy, FJ, et al. Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am J Physiol Gastriointest Liver Physiol 2005;288:G251–G260.Google Scholar

Tomer, G, Ananthanarayanan, M, Weymann, A, et al. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr Res 2003;53:288–94.Google Scholar

Zinchuk, VS, Okada, T, Akimaru, K, et al. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Phys – Gastr L. 2002;282:G540–G548.Google Scholar

Wagner, M, Zollner, G, Trauner, M. Nuclear receptors in liver disease. Hepatology 2011;53:1023–34.Google Scholar

Balistreri, WF, Suchy, FJ, Farrell, MK, Heubi, JE. Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease. J Pediatr 1981;98:399–402.Google Scholar

Spivak, W, Grand, RJ. General configuration of cholestasis in the newborn. J Pediatr Gastroenterol Nutr 1983;2:381–92.Google Scholar

Yang, T, Khan, GJ, Wu, Z, Wang, X, Zhang, L, Jiang, Z. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases. Drug Discov Today 2019;24:112–28.Google Scholar

Popper, H. Cholestasis: the future of a past and present riddle. Hepatology 1981;1:187–91.Google Scholar

Hofmann, AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007;6:15–27.Google Scholar

Fickert, P, Wagner, M. Biliary bile acids in hepatobiliary injury – What is the link? J Hepatol 2017;67:619–31.Google Scholar

Lester, R. Physiologic cholestasis. Gastroenterology 1980;78:864–5.Google Scholar

Fawaz, R, Baumann, U, Ekong, U, Fischler, B, Hadzic, N, Mack, CL, McLin, VA, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2017;64:154–68.Google Scholar

Feldman, AG, Sokol, RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol 2019;16:346–60.Google Scholar

Trauner, M, Fuchs, CD, Halilbasic, E, Paumgartner, G. New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology 2017;65:1393–1404.Google Scholar

Tabibian, JH, Masyuk, AI, Masyuk, TV, O’Hara, SP, Larusso, NF. Physiology of cholangiocytes. Compr Physiol 2013;3:541–65.Google Scholar

Dawson, PA, Karpen, SJ. Intestinal transport and metabolism of bile acids. J Lipid Res 2015;56:1085–99.Google Scholar

Jansen, PL, Ghallab, A, Vartak, N, Reif, R, Schaap, FG, Hampe, J, Hengstler, JG. The ascending pathophysiology of cholestatic liver disease. Hepatology 2017;65:722–38.Google Scholar

Li, J, Dawson, PA. Animal models to study bile acid metabolism. Biochim Biophys Acta Mol Basis Dis 2019;1865:895–911.Google Scholar

Heubi, JE, Setchell, KDR, Bove, KE. Inborn errors of bile acid metabolism. Clin Liver Dis 2018;22:671–87.Google Scholar

Strautnieks, SS, Bull, LN, Knisely, AS, Kocoshis, SA, Dahl, N, Arnell, H, Sokal, E, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Gen 1998;20:233–8.Google Scholar

Borgstroem, B, Lundh, G, Hofmann, A. The site of absorption of conjugated bile salts in man. Gastroenterology 1963;45:229–38.Google Scholar

Wong, MH, Oelkers, P, Craddock, AL, Dawson, PA. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 1994;269:1340–7.Google Scholar

Dawson, PA, Hubbert, M, Haywood, J, Craddock, AL, Zerangue, N, Christian, WV, Ballatori, N. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 2005;280:6960–8.Google Scholar

Hagenbuch, B, Lubbert, H, Stieger, B, Meier, PJ. Expression of the hepatocyte Na⁺/bile acid cotransporter in Xenopus laevis oocytes. J Biol Chem 1990;265:5357–60.Google Scholar

Orntoft, NW, Munk, OL, Frisch, K, Ott, P, Keiding, S, Sorensen, M. Hepatobiliary transport kinetics of the conjugated bile acid tracer (11)C-CSar quantified in healthy humans and patients by positron emission tomography. J Hepatol 2017;67:321–7.Google Scholar

Ridlon, JM, Harris, SC, Bhowmik, S, Kang, DJ, Hylemon, PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016;7:22–39.Google Scholar

Yan, H, Zhong, G, Xu, G, He, W, Jing, Z, Gao, Z, Huang, Y, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012;1:e00049.Google Scholar

Hu, HH, Liu, J, Lin, YL, Luo, WS, Chu, YJ, Chang, CL, Jen, CL, et al. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut 2016;65:1514–21.Google Scholar

Li, W, Urban, S. Entry of hepatitis B and hepatitis D virus into hepatocytes: basic insights and clinical implications. J Hepatol 2016;64:S32–S40.Google Scholar

Dawson, PA. Hepatic bile acid uptake in humans and mice: multiple pathways and expanding potential role for gut-liver signaling. Hepatology 2017;66:1384–6.Google Scholar

Slijepcevic, D, Roscam Abbing, RLP, Katafuchi, T, Blank, A, Donkers, JM, van Hoppe, S, de Waart, DR, et al. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice. Hepatology 2017;66:1631–43.Google Scholar

Slijepcevic, D, van de Graaf, SF. Bile acid uptake transporters as targets for therapy. Dig Dis 2017;35:251–8.Google Scholar

Vaz, FM, Paulusma, CC, Huidekoper, H, de Ru, M, Lim, C, Koster, J, Ho-Mok, K, et al. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. Hepatology 2015;61:260–7.Google Scholar

Karpen, SJ, Dawson, PA. Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defect. Hepatology 2015;61:24–7.Google Scholar

Suchy, FJ, Ananthanarayanan, M. Bile salt excretory pump: biology and pathobiology. J Pediatr Gastroenterol Nutr 2006;43(Suppl1):S10–16.Google Scholar

Stieger, B. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metabolism Reviews 2010;42:437–45. http://dx.doi.org/10.3109/03602530903492004Google Scholar

Davit-Spraul, A, Fabre, M, Branchereau, S, Baussan, C, Gonzales, E, Stieger, B, Bernard, O, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010;51:1645–55.Google Scholar

Groen, A, Romero, MR, Kunne, C, Hoosdally, SJ, Dixon, PH, Wooding, C, Williamson, C, et al. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. Gastroenterology 2011;141:1927–37.Google Scholar

Keitel, V, Nies, A, Brom, M, Hummel-Eisenbeiss, J, Spring, H, Keppler, D. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003;284:G165–74.Google Scholar

Corpechot, C, Barbu, V, Chazouilleres, O, Broue, P, Girard, M, Roquelaure, B, Chretien, Y, et al. Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders. Liver Int 2020;40:163–74.Google Scholar

Lazaridis, KN, LaRusso, NF. The cholangiopathies. Mayo Clin Proc 2015;90:791–800.Google Scholar

Banales, JM, Huebert, RC, Karlsen, T, Strazzabosco, M, LaRusso, NF, Gores, GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol 2019;16:269–81.Google Scholar

Fabris, L, Fiorotto, R, Spirli, C, Cadamuro, M, Mariotti, V, Perugorria, MJ, Banales, JM, et al. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases. Nat Rev Gastroenterol Hepatol 2019;16:497–511.Google Scholar

Beuers, U, Maroni, L, Elferink, RO. The biliary HCO(3)(-) umbrella: experimental evidence revisited. Curr Opin Gastroenterol 2012;28:253–7.Google Scholar

Maillette de Buy Wenniger, LJ, Hohenester, S, Maroni, L, van Vliet, SJ, Oude Elferink, RP, Beuers, U. The cholangiocyte glycocalyx stabilizes the “biliary HCO3 umbrella”: an integrated line of defense against toxic bile acids. Dig Dis 2015;33:397–407.Google Scholar

Masyuk, AI, Masyuk, TV, LaRusso, NF. Cholangiocyte primary cilia in liver health and disease. Dev Dyn 2008;237:2007–12.Google Scholar

Larusso, NF, Masyuk, TV. The role of cilia in the regulation of bile flow. Dig Dis 2011;29:6–12.Google Scholar

Perugorria, MJ, Masyuk, TV, Marin, JJ, Marzioni, M, Bujanda, L, LaRusso, NF, Banales, JM. Polycystic liver diseases: advanced insights into the molecular mechanisms. Nat Rev Gastroenterol Hepatol 2014;11:750–61.Google Scholar

Ghallab, A, Hofmann, U, Sezgin, S, Vartak, N, Hassan, R, Zaza, A, Godoy, P, et al. Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood. Hepatology 2019;69:666–83.Google Scholar

Watkins, JB, Ingall, D, Szczepanik, P, Klein, PD, Lester, R. Bile-salt metabolism in the newborn. Measurement of pool size and synthesis by stable isotope technic. N Engl J Med 1973;288:431–4.Google Scholar

Suchy, FJ, Balistreri, WF, Heubi, JE, Searcy, JE, Levin, RS. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80:1037–41.Google Scholar

Balistreri, WF, Heubi, JE, Suchy, FJ. Immaturity of the enterohepatic circulation in early life: factors predisposing to “physiologic” maldigestion and cholestasis. J Pediatr Gastroenterol Nutr 1983;2:346–54.Google Scholar

Khandekar, G, Llewellyn, J, Kriegermeier, A, Waisbourd-Zinman, O, Johnson, N, Du, Y, Giwa, R, et al. Coordinated development of the mouse extrahepatic bile duct: implications for neonatal susceptibility to biliary injury. J Hepatol 2020;72:135–45.Google Scholar

Karpen, SJ, Trauner, M. The new therapeutic frontier–nuclear receptors and the liver. J Hepatol 2010;52:455–62.Google Scholar

Wagner, M, Zollner, G, Trauner, M. Nuclear receptors in liver disease. Hepatology 2011;53:1023–34.Google Scholar

Arab, JP, Karpen, SJ, Dawson, PA, Arrese, M, Trauner, M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology 2017;65:350–62.Google Scholar

Karpen, SJ, Trauner, M. The new therapeutic frontier–nuclear receptors and the liver. J Hepatol 2010;52:455–62.Google Scholar

Keitel, V, Droge, C, Haussinger, D. Targeting FXR in cholestasis. Handb Exp Pharmacol 2019;256:299–324.Google Scholar

Keitel, V, Haussinger, D. Role of TGR5 (GPBAR1) in liver disease. Semin Liver Dis 2018;38:333–9.Google Scholar

Nevens, F, Andreone, P, Mazzella, G, Strasser, SI, Bowlus, C, Invernizzi, P, Drenth, JP, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 2016;375:631–43.Google Scholar

Chen, XQ, Wang, LL, Shan, QW, Tang, Q, Deng, YN, Lian, SJ, Yun, X. A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis. World J Pediatr 2012;8:67–71.Google Scholar

Gomez-Ospina, N, Potter, CJ, Xiao, R, Manickam, K, Kim, MS, Kim, KH, Shneider, BL, et al. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis. Nat Commun 2016;7:10713.Google Scholar

Karlsen, TH, Lammert, F, Thompson, RJ. Genetics of liver disease: from pathophysiology to clinical practice. J Hepatol 2015;62:S6–S14.Google Scholar

Nicolaou, M, Andress, EJ, Zolnerciks, JK, Dixon, PH, Williamson, C, Linton, KJ. Canalicular ABC transporters and liver disease. J Pathol 2012;226:300–15.Google Scholar

Grammatikopoulos, T, Sambrotta, M, Strautnieks, S, Foskett, P, Knisely, AS, Wagner, B, Deheragoda, M, et al. Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis. J Hepatol 2016;65:1179–87.Google Scholar

Maddirevula, S, Alhebbi, H, Alqahtani, A, Algoufi, T, Alsaif, HS, Ibrahim, N, Abdulwahab, F, et al. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants. Genet Med 2019;21:1164–72.Google Scholar

Unlusoy Aksu, A, Das, SK, Nelson-Williams, C, Jain, D, Ozbay Hosnut, F, Evirgen Sahin, G, Lifton, RP, et al. Recessive mutations in KIF12 cause high gamma-glutamyltransferase cholestasis. Hepatol Commun 2019;3:471–7.Google Scholar

Sultan, M, Rao, A, Elpeleg, O, Vaz, FM, Abu Libdeh, BY, Karpen, SJ, Dawson, PA. Organic solute transporter-beta (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis. Hepatology 2018;68:590–98.Google Scholar

Berauer, JP, Mezina, AI, Okou, DT, Sabo, A, Muzny, DM, Gibbs, RA, Hegde, MR, et al. Identification of polycystic kidney disease 1 like 1 gene variants in children with biliary atresia splenic malformation syndrome. Hepatology 2019;70:899–910.Google Scholar

Shagrani, M, Burkholder, J, Broering, D, Abouelhoda, M, Faquih, T, El-Kalioby, M, Subhani, SN, et al. Genetic profiling of children with advanced cholestatic liver disease. Clin Genet 2017;92:52–61.Google Scholar

Nicastro, E, D’Antiga, L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl 2018;24:282–93.Google Scholar

Osler, W. (1901). Principles and Practice of Medicine (p. 550). New York: Appleton and Company.Google Scholar

Kosters, A, Karpen, SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010;30:186–94.Google Scholar

Dunham, EC. Septicemia in the new-born. Am J Dis Child 1933;45:229–53.Google Scholar

Utili, R, Abernathy, C, Zimmerman, H. Endotoxin effects on the liver. Life Sci 1977;20:553–68.Google Scholar

Tacke, F, Luedde, T, Trautwein, C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009;36:4–12.Google Scholar

Strnad, P, Tacke, F, Koch, A, Trautwein, C. Liver – guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 2017;14:55–66.Google Scholar

Moshage, H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–66.Google Scholar

Padda, MS, Sanchez, M, Akhtar, AJ, Boyer, JL. Drug-induced cholestasis. Hepatology 2011;53:1377–87.Google Scholar

Hoofnagle, JH, Bjornsson, ES. Drug-induced liver injury – types and phenotypes. N Engl J Med 2019;381:264–73.Google Scholar

Woolbright, BL, Jaeschke, H. Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity. Curr Pharmacol Rep 2018;4:346–57.Google Scholar

Kearns, G, Abdel-Rahman, S, Alander, S, Blowey, D, Leeder, J, Kauffman, R. Developmental pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157–67.Google Scholar

Zollner, G, Wagner, M, Trauner, M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther 2010;126:228–43.Google Scholar

Trauner, M, Baghdasaryan, A, Claudel, T, Fickert, P, Halilbasic, E, Moustafa, T, Zollner, G. Targeting nuclear bile acid receptors for liver disease. Dig Dis 2011;29:98–102.Google Scholar

Carter, BA, Karpen, SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis 2007;27:251–8.Google Scholar

Lee, WS, Sokol, RJ. Intestinal microbiota, lipids, and the pathogenesis of intestinal failure-associated liver disease. J Pediatr 2015;167:519–26.Google Scholar

El Kasmi, KC, Vue, PM, Anderson, AL, Devereaux, MW, Ghosh, S, Balasubramaniyan, N, Fillon, SA, et al. Macrophage-derived IL-1beta/NF-kappaB signaling mediates parenteral nutrition-associated cholestasis. Nat Commun 2018;9:1393.Google Scholar

Rochling, FA, Catron, HA. Intestinal failure-associated liver disease: causes, manifestations and therapies. Curr Opin Gastroenterol 2019;35:126–33.Google Scholar

Pironi, L, Sasdelli, AS. Intestinal failure-associated liver disease. Clin Liver Dis 2019;23:279–91.Google Scholar

Josephson, J, Turner, JM, Field, CJ, Wizzard, PR, Nation, PN, Sergi, C, Ball, RO, et al. Parenteral soy oil and fish oil emulsions: impact of dose restriction on bile flow and brain size of parenteral nutrition-fed neonatal piglets. JPEN J Parenter Enteral Nutr 2015;39:677–87.Google Scholar

Koelfat, KVK, Schaap, FG, Hodin, C, Visschers, RGJ, Svavarsson, BI, Lenicek, M, Shiri-Sverdlov, R, et al. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease. Clin Nutr 2017;36:1403–10.Google Scholar

Mutanen, A, Lohi, J, Heikkila, P, Jalanko, H, Pakarinen, MP. Liver inflammation relates to decreased canalicular bile transporter expression in pediatric onset intestinal failure. Ann Surg 2018:268(2):332–9.Google Scholar

Lam, CKL, Church, PC, Haliburton, B, Chambers, K, Martincevic, I, Vresk, L, Courtney-Martin, G, et al. Long-term exposure of children to a mixed lipid emulsion is less hepatotoxic than soybean-based lipid emulsion. J Pediatr Gastroenterol Nutr 2018;66:501–4.Google Scholar

Carter, BA, Taylor, OA, Prendergast, DR, Zimmerman, TL, Von Furstenberg, R, Moore, DD, Karpen, SJ. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007;62:301–6.Google Scholar

Isaac, DM, Alzaben, AS, Mazurak, VC, Yap, J, Wizzard, PR, Nation, PN, Zhao, YY, et al. Mixed lipid, fish oil and soybean oil parenteral lipids impact cholestasis, hepatic phytosterol and lipid composition. J Pediatr Gastroenterol Nutr 2019;68:861–7.Google Scholar

Rochling, FA, Catron, HA. Intestinal failure-associated liver disease: causes, manifestations and therapies. Curr Opin Gastroenterol 2019;35:126–33.Google Scholar

Fuchs, CD, Schwabl, P, Reiberger, T, Trauner, M. Liver capsule: FXR agonists against liver disease. Hepatology 2016;64:1773.Google Scholar

Pradhan-Sundd, T, Zhou, L, Vats, R, Jiang, A, Molina, L, Singh, S, Poddar, M, et al. Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis. Hepatology 2018;67:2320–37.Google Scholar

Pradhan-Sundd, T, Monga, SP. Blood-bile barrier: morphology, regulation, and pathophysiology. Gene Expr 2019;19:69–87.Google Scholar

Hofmann, AF. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 2003;52:1239–41.Google Scholar

Miethke, AG, Zhang, W, Simmons, J, Taylor, AE, Shi, T, Shanmukhappa, SK, Karns, R, et al. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology 2016;63:512–23.Google Scholar

Fuchs, CD, Paumgartner, G, Mlitz, V, Kunczer, V, Halilbasic, E, Leditznig, N, Wahlstrom, A, et al. Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids. Gut 2018;67:1683–91.Google Scholar

Poupon, R. ASBT inhibitors in cholangiopathies – Good for mice, good for men? J Hepatol 2016;64:537–8.Google Scholar

Karpen, SJ. Novel bile acid therapies for liver disease. Gastroenterol Hepatol 2018;14:117–19.Google Scholar

Hakim, A, Zhang, X, DeLisle, A, Oral, EA, Dykas, D, Drzewiecki, K, Assis, DN, et al. Clinical utility of genomic analysis in adults with idiopathic liver disease. J Hepatol 2019;70:1214–21.Google Scholar

Schaap, FG, Trauner, M, Jansen, PL. Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 2014;11:55–67.Google Scholar

Narkewicz, MR, Horslen, S, Hardison, RM, Shneider, BL, Rodriguez-Baez, N, Alonso, EM, Ng, VL, et al. A learning collaborative approach increases specificity of diagnosis of acute liver failure in pediatric patients. Clin Gastroenterol Hepatol 2018;16:1801–10 e1803.Google Scholar

Squires, JE, McKiernan, P, Squires, RH. Acute liver failure: an update. Clin Liver Dis 2018;22:773–805.Google Scholar

Kim, WR, Lake, JR, Smith, JM, Skeans, MA, Schladt, DP, Edwards, EB, Harper, AM, et al. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant 2015;15(Suppl 2):1–28.Google Scholar

Ng, VL, Li, R, Loomes, KM, Leonis, MA, Rudnick, DA, Belle, SH, Squires, RH, et al. Outcomes of children with and without hepatic encephalopathy from the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr 2016;63:357–64.Google Scholar

Squires, RH Jr., Shneider, BL, Bucuvalas, J, Alonso, E, Sokol, RJ, Narkewicz, MR, Dhawan, A, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652–8.Google Scholar

Alonso, EM, Horslen, SP, Behrens, EM, Doo, E. Pediatric acute liver failure of undetermined cause: a research workshop. Hepatology 2017;65:1026–37.Google Scholar

Alam, S, Khanna, R, Sood, V, Lal, BB, Rawat, D. Profile and outcome of the first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int 2017;37:1508–14.Google Scholar

Tannuri, AC, Porta, G, Kazue Miura, I, Santos, MM, Moreira Dde, A, de Rezende, NM, Miyatani, HT, et al. Pediatric acute liver failure in Brazil: is living donor liver transplantation the best choice for treatment? Liver Transpl 2016;22:1006–13.Google Scholar

Narkewicz, MR, Dell Olio, D, Karpen, SJ, Murray, KF, Schwarz, K, Yazigi, N, Zhang, S, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155:801–6 e801.Google Scholar

Schwarz, KB, Dell Olio, D, Lobritto, SJ, Lopez, MJ, Rodriguez-Baez, N, Yazigi, NA, Belle, SH, et al. Analysis of viral testing in nonacetaminophen pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2014;59:616–23.Google Scholar

Valencia, CA, Wang, X, Wang, J, Peters, A, Simmons, JR, Moran, MC, Mathur, A, et al. Deep sequencing reveals novel genetic variants in children with acute liver failure and tissue evidence of impaired energy metabolism. PLoS One 2016;11:e0156738.Google Scholar

Vilarinho, S, Choi, M, Jain, D, Malhotra, A, Kulkarni, S, Pashankar, D, Phatak, U, et al. Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. J Hepatol 2014;61:1056–63.Google Scholar

Azhar, N, Ziraldo, C, Barclay, D, Rudnick, DA, Squires, RH, Vodovotz, Y. Pediatric Acute Liver Failure Study Group. Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One 2013;8:e78202.Google Scholar

Zamora, R, Vodovotz, Y, Mi, Q, Barclay, D, Yin, J, Horslen, S, Rudnick, D, et al. Data-driven modeling for precision medicine in pediatric acute liver failure. Mol Med 2017;22:821–9.Google Scholar

Bucuvalas, J, Filipovich, L, Yazigi, N, Narkewicz, MR, Ng, V, Belle, SH, Zhang, S, et al. Immunophenotype predicts outcome in pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2013;56:311–15.Google Scholar

McKenzie, RB, Berquist, WE, Nadeau, KC, Louie, CY, Chen, SF, Sibley, RK, Glader, BE, et al. Novel protocol including liver biopsy to identify and treat CD8+ T-cell predominant acute hepatitis and liver failure. Pediatr Transplant 2014;18:503–9.Google Scholar

Chapin, CA, Burn, T, Meijome, T, Loomes, KM, Melin-Aldana, H, Kreiger, PA, Whitington, PF, et al. Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate. Hepatology 2018;68:1087–1100.Google Scholar

Chapin, CA, Horslen, SP, Squires, JE, Lin, H, Blondet, N, Mohammad, S, Alonso, EM. Corticosteroid therapy for indeterminate pediatric acute liver failure and aplastic anemia with acute hepatitis. J Pediatr 2019;208:23–9.Google Scholar

Li, R, Belle, SH, Horslen, S, Chen, LW, Zhang, S, Squires, RH. Pediatric Acute Liver Failure Study Group. Clinical course among cases of acute liver failure of indeterminate diagnosis. J Pediatr 2016;171:163–70 e161–163.Google Scholar

Squires, JE, Rudnick, DA, Hardison, RM, Horslen, S, Ng, VL, Alonso, EM, Belle, SH, et al. Liver transplant listing in pediatric acute liver failure: practices and participant characteristics. Hepatology 2018;68:2338–47.Google Scholar

Ramachandran, A, Jaeschke, H. Acetaminophen hepatotoxicity. Semin Liver Dis 2019; 39(2):221–34.Google Scholar

Lee, WM. Acetaminophen (APAP) hepatotoxicity-Isn’t it time for APAP to go away? J Hepatol 2017;67:1324–31.Google Scholar

Rumack, BH. Acetaminophen overdose in children and adolescents. Pediatr Clin North Am 1986;33:691–701.Google Scholar

Zamora, R, Barclay, D, Yin, J, Alonso, EM, Leonis, MA, Mi, Q, Billiar, TR, et al. HMGB1 is a central driver of dynamic pro-inflammatory networks in pediatric acute liver failure induced by acetaminophen. Sci Rep 2019;9:5971.Google Scholar

Saito, C, Zwingmann, C, Jaeschke, H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010;51:246–54.Google Scholar

Heubi, JE, Barbacci, MB, Zimmerman, HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998;132:22–7.Google Scholar

Court, MH, Freytsis, M, Wang, X, Peter, I, Guillemette, C, Hazarika, S, Duan, SX, et al. The UDP-glucuronosyltransferase (UGT) 1 A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther 2013;345: 297–307.Google Scholar

Linakis, MW, Cook, SF, Kumar, SS, Liu, X, Wilkins, DG, Gaedigk, R, Gaedigk, A, et al. Polymorphic expression of UGT1A9 is associated with variable acetaminophen glucuronidation in neonates: a population pharmacokinetic and pharmacogenetic study. Clin Pharmacokinet 2018;57:1325–36.Google Scholar

James, LP, Alonso, EM, Hynan, LS, Hinson, JA, Davern, TJ, Lee, WM, Squires, RH, et al. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006;118:e676–681.Google Scholar

Alonso, EM, James, LP, Zhang, S, Squires, RH, Pediatric Acute Liver Failure Study Group. Acetaminophen adducts detected in serum of pediatric patients with acute liver failure. J Pediatr Gastroenterol Nutr 2015;61:102–7.Google Scholar

Devarbhavi, H, Patil, M, Reddy, VV, Singh, R, Joseph, T, Ganga, D. Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients. Liver Int 2018;38:1322–9.Google Scholar

Amin, MD, Harpavat, S, Leung, DH. Drug-induced liver injury in children. Curr Opin Pediatr 2015;27:625–33.Google Scholar

Narkewicz, MR, Horslen, S, Belle, SH, Rudnick, DA, Ng, VL, Rosenthal, P, Romero, R, et al. Prevalence and significance of autoantibodies in children with acute liver failure. J Pediatr Gastroenterol Nutr 2017;64:210–17.Google Scholar

Stravitz, RT, Lefkowitch, JH, Fontana, RJ, Gershwin, ME, Leung, PS, Sterling, RK, Manns, MP, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517–26.Google Scholar

Chinn, IK, Eckstein, OS, Peckham-Gregory, EC, Goldberg, BR, Forbes, LR, Nicholas, SK, Mace, EM, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood 2018;132:89–100.Google Scholar

Chandrakasan, S, Filipovich, AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr 2013;163:1253–9.Google Scholar

Picard, C, Bobby Gaspar, H, Al-Herz, W, Bousfiha, A, Casanova, JL, Chatila, T, Crow, YJ, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol 2018;38:96–128.Google Scholar

Grunebaum, E, Avitzur, Y. Liver-associated immune abnormalities. Autoimmun Rev 2019;18:15–20.Google Scholar

Taylor, SA, Whitington, PF. Neonatal acute liver failure. Liver Transpl 2016;22:677–85.Google Scholar

Whitington, PF. Gestational alloimmune liver disease and neonatal hemochromatosis. Semin Liver Dis 2012;32:325–32.Google Scholar

Sundaram, SS, Alonso, EM, Narkewicz, MR, Zhang, S, Squires, RH. Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J Pediatr 2011;159:813–18 e811.Google Scholar

Li, H, Byers, HM, Diaz-Kuan, A, Vos, MB, Hall, PL, Tortorelli, S, Singh, R, et al. Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas. Mol Genet Metab 2018;123:428–32.Google Scholar

Staufner, C, Haack, TB, Kopke, MG, Straub, BK, Kolker, S, Thiel, C, Freisinger, P, et al. Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis 2016;39:3–16.Google Scholar

Squires, RH, Ng, V, Romero, R, Ekong, U, Hardikar, W, Emre, S, Mazariegos, GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 2014;60:362–98.Google Scholar

Parikh, S, Karaa, A, Goldstein, A, Ng, YS, Gorman, G, Feigenbaum, A, Christodoulou, J, et al. Solid organ transplantation in primary mitochondrial disease: proceed with caution. Mol Genet Metab 2016;118:178–84.Google Scholar

Feldman, AG, Sokol, RJ, Hardison, RM, Alonso, EM, Squires, RH, Narkewicz, MR. Pediatric Acute Liver Failure Study Group. Lactate and lactate: pyruvate ratio in the diagnosis and outcomes of pediatric acute liver failure. J Pediatr 2017;182:217–22 e213.Google Scholar

Casey, JP, Slattery, S, Cotter, M, Monavari, AA, Knerr, I, Hughes, J, Treacy, EP, et al. Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis 2015;38:1085–92.Google Scholar

Shneider, BL, Rinaldo, P, Emre, S, Bucuvalas, J, Squires, R, Narkewicz, M, Gondolesi, G, et al. Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology 2005;41:717–21.Google Scholar

Faghfoury, H, Baruteau, J, de Baulny, HO, Haberle, J, Schulze, A. Transient fulminant liver failure as an initial presentation in citrullinemia type I. Mol Genet Metab 2011;102:413–17.Google Scholar

Gallagher, RC, Lam, C, Wong, D, Cederbaum, S, Sokol, RJ. Significant hepatic involvement in patients with ornithine transcarbamylase deficiency. J Pediatr 2014;164:720–5 e726.Google Scholar

Korman, JD, Volenberg, I, Balko, J, Webster, J, Schiodt, FV, Squires, RH Jr., Fontana, RJ, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008;48:1167–74.Google Scholar

Pandit, A, Mathew, LG, Bavdekar, A, Mehta, S, Ramakrishnan, G, Datta, S, Liu, YF. Hepatotropic viruses as etiological agents of acute liver failure and related-outcomes among children in India: a retrospective hospital-based study. BMC Res Notes 2015;8:381.Google Scholar

Poddar, U, Thapa, BR, Prasad, A, Singh, K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J Trop Pediatr 2002;48:210–13.Google Scholar

Safadi, R, Or, R, Ilan, Y, Naparstek, E, Nagler, A, Klein, A, Ketzinel-Gilaad, M, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001;27:183–90.Google Scholar

Phillips, MJ, Blendis, LM, Poucell, S, Offterson, J, Petric, M, Roberts, E, Levy, GA, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 1991;324:455–60.Google Scholar

Ojetti, V, Fini, L, Zileri Dal Verme, L, Migneco, A, Pola, P, Gasbarrini, A. Acute cryptogenic liver failure in an untreated coeliac patient: a case report. Eur J Gastroenterol Hepatol 2005;17:1119–21.Google Scholar

Heymann, F, Tacke, F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol 2016;13:88–110.Google Scholar

Ramachandran, A, Jaeschke, H. Acetaminophen hepatotoxicity. Semin Liver Dis 2019;39:221–34.Google Scholar

Real, M, Barnhill, MS, Higley, C, Rosenberg, J, Lewis, JH. Drug-induced liver injury: highlights of the recent literature. Drug Saf 2019;42:365–87.Google Scholar

Mi, Q, Li, NY, Ziraldo, C, Ghuma, A, Mikheev, M, Squires, R, Okonkwo, DO, et al. Translational systems biology of inflammation: potential applications to personalized medicine. Per Med 2010;7:549–59.Google Scholar

Zamora, R, Vodovotz, Y, Mi, Q, Barclay, D, Yin, J, Horslen, S, Rudnick, D, et al. Data-driven modeling for precision medicine in pediatric acute liver failure. Mol Med 2016;22:821–9.Google Scholar

Possamai, LA, Thursz, MR, Wendon, JA, Antoniades, CG. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol 2014;61:439–45.Google Scholar

Stout, RD, Jiang, C, Matta, B, Tietzel, I, Watkins, SK, Suttles, J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005;175:342–9.Google Scholar

Antoniades, CG, Berry, PA, Wendon, JA, Vergani, D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008;49:845–61.Google Scholar

Rolando, N, Wade, J, Davalos, M, Wendon, J, Philpott-Howard, J, Williams, R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734–9.Google Scholar

Michalopoulos, GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013;3:485–513.Google Scholar

Huang, J, Schriefer, AE, Cliften, PF, Dietzen, D, Kulkarni, S, Sing, S, Monga, SP, et al. Postponing the hypoglycemic response to partial hepatectomy delays mouse liver regeneration. Am J Pathol 2016;186:587–99.Google Scholar

Rudnick, DA, Dietzen, DJ, Turmelle, YP, Shepherd, R, Zhang, S, Belle, SH, Squires, R, et al. Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 2009;13:223–30.Google Scholar

Chapin, CA, Mohammad, S, Bass, LM, Taylor, SA, Kelly, S, Alonso, EM. Liver biopsy can be safely performed in pediatric acute liver failure to aid in diagnosis and management. J Pediatr Gastroenterol Nutr 2018;67:441–5.Google Scholar

Alonso, EM, Sokol, RJ, Hart, J, Tyson, RW, Narkewicz, MR, Whitington, PF. Fulminant hepatitis associated with centrilobular hepatic necrosis in young children. J Pediatr 1995;127:888–94.Google Scholar

Squires, RH Jr. Acute liver failure in children. Semin Liver Dis 2008;28:153–66.Google Scholar

Hussain, E, Grimason, M, Goldstein, J, Smith, CM, Alonso, E, Whitington, PF, Wainwright, MS. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr 2014;58:449–56.Google Scholar

Press, CA, Morgan, L, Mills, M, Stack, CV, Goldstein, JL, Alonso, EM, Wainwright, MS. Spectral electroencephalogram analysis for the evaluation of encephalopathy grade in children with acute liver failure. Pediatr Crit Care Med 2017;18:64–72.Google Scholar

Kamat, P, Kunde, S, Vos, M, Vats, A, Gupta, N, Heffron, T, Romero, R, et al. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 2012;13:e33–38.Google Scholar

Srivastava, A, Yadav, SK, Borkar, VV, Yadav, A, Yachha, SK, Thomas, MA, Rathore, RK, et al. Serial evaluation of children with ALF with advanced MRI, serum proinflammatory cytokines, thiamine, and cognition assessment. J Pediatr Gastroenterol Nutr 2012;55:580–6.Google Scholar

Shawcross, DL, Wendon, JA. The neurological manifestations of acute liver failure. Neurochem Int 2012;60:662–71.Google Scholar

Kawada, PS, Bruce, A, Massicotte, P, Bauman, M, Yap, J. Coagulopathy in children with liver disease. J Pediatr Gastroenterol Nutr 2017;65:603–7.Google Scholar

Lisman, T, Stravitz, RT. Rebalanced hemostasis in patients with acute liver failure. Semin Thromb Hemost 2015;41:468–73.Google Scholar

Barton, CA. Treatment of coagulopathy related to hepatic insufficiency. Crit Care Med 2016;44:1927–33.Google Scholar

Stravitz, RT, Lisman, T, Luketic, VA, Sterling, RK, Puri, P, Fuchs, M, Ibrahim, A, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012;56:129–36.Google Scholar

Patel, KR, Bertuch, A, Sasa, GS, Himes, RW, Wu, H. Features of hepatitis in hepatitis-associated aplastic anemia: clinical and histopathologic study. J Pediatr Gastroenterol Nutr 2017;64:e7–e12.Google Scholar

Molina, RA, Katzir, L, Rhee, C, Ingram-Drake, L, Moore, T, Krogstad, P, Martin, MG. Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant 2004;4:1656–61.Google Scholar

Leventhal, TM, Liu, KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis 2015;22:376–81.Google Scholar

Jain, V, Dhawan, A. Extracorporeal liver support systems in paediatric liver failure. J Pediatr Gastroenterol Nutr 2017;64:855–63.Google Scholar

Kiss, JE, Berman, D, Van Thiel, D. Effective removal of copper by plasma exchange in fulminant Wilson’s disease. Transfusion 1998;38:327–31.Google Scholar

Singer, AL, Olthoff, KM, Kim, H, Rand, E, Zamir, G, Shaked, A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001;234:418–24.Google Scholar

Larsen, FS, Schmidt, LE, Bernsmeier, C, Rasmussen, A, Isoniemi, H, Patel, VC, Triantafyllou, E, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016;64:69–78.Google Scholar

Hanish, SI, Stein, DM, Scalea, JR, Essien, EO, Thurman, P, Hutson, WR, Bartlett, ST, et al. Molecular adsorbent recirculating system effectively replaces hepatic function in severe acute liver failure. Ann Surg 2017;266:677–84.Google Scholar

Lexmond, WS, Van Dael, CM, Scheenstra, R, Goorhuis, JF, Sieders, E, Verkade, HJ, Van Rheenen, PF, et al. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl 2015;21:369–80.Google Scholar

Lu, BR, Zhang, S, Narkewicz, MR, Belle, SH, Squires, RH, Sokol, RJ. Pediatric Acute Liver Failure Study Group. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr 2013;162:1010–16 e1011–14.Google Scholar

Sundaram, V, Shneider, BL, Dhawan, A, Ng, VL, Im, K, Belle, S, Squires, RH. King’s College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr 2013;162:319–23 e311.Google Scholar

Rajanayagam, J, Frank, E, Shepherd, RW, Lewindon, PJ. Artificial neural network is highly predictive of outcome in paediatric acute liver failure. Pediatr Transplant 2013;17:535–42.Google Scholar

Kumar, R, Shalimar, Sharma H, Goyal, R, Kumar, A, Khanal, S, Prakash, S, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 2012;61:1068–75.Google Scholar

Deep, A, Stewart, CE, Dhawan, A, Douiri, A. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 2016;44:1910–19.Google Scholar

Lutfi, R, Abulebda, K, Nitu, ME, Molleston, JP, Bozic, MA, Subbarao, G. Intensive care management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2017;64:660–70.Google Scholar

Mack, CL, Ferrario, M, Abecassis, M, Whitington, PF, Superina, RA, Alonso, EM. Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure. Liver Transpl 2001;7:890–5.Google Scholar

Ciria, R, Davila, D, Heaton, N. Auxiliary liver transplantation in children. Curr Opin Organ Transplant 2011;16:489–93.Google Scholar

Sorensen, LG, Neighbors, K, Zhang, S, Limbers, CA, Varni, JW, Ng, VL, Squires, RH, et al. Neuropsychological functioning and health-related quality of life: pediatric acute liver failure study group results. J Pediatr Gastroenterol Nutr 2015;60:75–83.Google Scholar

Squires, JE, Soltys, KA, McKiernan, P, Squires, RH, Strom, SC, Fox, IJ, Clinical hepatocyte, Soto-Gutierrez A transplantation: what is next? Curr Transplant Rep 2017;4:280–9.Google Scholar

Psacharopoulos, HT, Mowat, AP, Davies, M, Portmann, B, Silk, DB, Williams, R. Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child 1980;55:252–8.Google Scholar

Mondragon, R, Mieli-Vergani, G, Heaton, ND, Mowat, AP, Vougas, V, Williams, R, Tan, KC. Liver transplantation for fulminant liver failure in children. Transpl Int 1992;5(Suppl 1):S206–8.Google Scholar

Garcia-Tsao, G, Friedman, S, Iredale, J, Pinzani, M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010;51(4):1445–9.Google Scholar

Pinzani, M, Rombouts, K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004;36(4):231–42.Google Scholar

Hernandez-Gea, V, Friedman, SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011;6(1):425–56.Google Scholar

Wells, RG. Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 2008;12(4):759–68.Google Scholar

Wells, RG. The role of matrix stiffness in regulating cell behavior. Hepatology 2008;47(4):1394–400.Google Scholar

Yoon, YJ, Friedman, SL, Lee, YA. Antifibrotic therapies: where are we now? Semin Liver Dis 2016;36(1):87–98.Google Scholar

Manka, P, Zeller, A, Syn, W-K. Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities. Drugs 2019;79(9):903–27.Google Scholar

Riehle, KJ, Dan, YY, Campbell, JS, Fausto, N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26 Suppl 1(2):203–12.Google Scholar

Satapathy, SK, Bernstein, D. Dermatologic disorders and the liver. Clin Liver Dis 2011;15(1):165–82.Google Scholar